Showing results (121-130 of 309) with videos related to

Sort By:
Pageof 31
Frontiers in Cellular and Infection Microbiology|February 17, 2022
HBeAg Is Indispensable for Inducing Liver Sinusoidal Endothelial Cell Activation by Hepatitis B VirusXiaohong Xie, Jinzhuo Luo, Dan Zhu, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2009
Evolution of raltegravir resistance during therapyNadine Sichtig, Saleta Sierra, Rolf Kaiser, et al.
Acta Bio-Medica : Atenei Parmensis|April 24, 2023
Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: ResponseOlga Izmailova, Oksana Shlykova, Alina Kabaliei, et al.
Frontiers in Immunology|November 9, 2020
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral CompoundsLara Schöler, Vu Thuy Khanh Le-Trilling, Mareike Eilbrecht, et al.
Plos One|June 2, 2021
Torque Teno Virus load in lung cancer patients correlates with age but not with tumor stageDirk Stefani, Balazs Hegedues, Stephane Collaud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
TLR1/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitroJia Liu, Min Jiang, Zhiyong Ma, et al.
Nature Communications|March 17, 2017
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growthJohanna C Klein, Katrin Moses, Gennadiy Zelinskyy, et al.
BMC Complementary Medicine and Therapies|January 22, 2026
Dose-dependent antiviral effects of glycyrrhizin, curcumin, and harmaline against clinical SARS-CoV-2 isolates, including D614G, Omicron BA.5, and Omicron XBB.1Rabea Grüneberg, Isabel Zydek, Carina Elsner, et al.
Frontiers in Immunology|July 11, 2022
Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough InfectionsBirte Möhlendick, Ieva Čiučiulkaitė, Carina Elsner, et al.
Archives of Virology|September 10, 2018
Evaluation of susceptibility of HIV-1 CRF01_AE variants to neutralization by a panel of broadly neutralizing antibodiesHongye Wang, Ting Yuan, Tingting Li, et al.
Pageof 31